MICROFLUORIMETRIC IDENTIFICATION AND ASSESSMENT OF PHYSIOLOGICAL-STATE OF LYMPHOCYTES AND NEUTROPHILS IN THE WHOLE NATIVE BLOOD BY MEANS OFFLUORESCENT PROBE-CATION DSM - CLINICAL AND EXPERIMENTAL-DATA
Gi. Morozova et al., MICROFLUORIMETRIC IDENTIFICATION AND ASSESSMENT OF PHYSIOLOGICAL-STATE OF LYMPHOCYTES AND NEUTROPHILS IN THE WHOLE NATIVE BLOOD BY MEANS OFFLUORESCENT PROBE-CATION DSM - CLINICAL AND EXPERIMENTAL-DATA, Gematologia i transfuziologia, 42(3), 1997, pp. 43-47
Microfluorimetric identification and assessment of physiological state
of lymphocytes and neutrophils in the whole native blood by means of
fluorescent probe-cation DSM: clinical and experimental data. G. I. Mo
rozova, N. A. Onischenko, I. G. Orzhekhovskaya, O. V. Polosina, F. Kh.
Bazieva, O. V. Baukina. Research Institute of Transplantology and Art
ificial Organs, Moscow, Russia. The authors present an original method
of identification of lymphocytes and neutrophils and assessment of th
eir mitochondrial activity in the whole native blood smear. The techni
que is based on the use of vital potential-sensitive fluorescent probe
-cation (4-p-dimethylaminostyryl-1-methylpyridinium (DSM) and microflu
orimetric technique. Clinical trial of the technique demonstrates: the
re are two phases of an increase in the mean intensity of mitochondria
l fluorescence intensity in the blood of patients with chronic hepatic
insufficiency before and after hemoperfusion through fragments of xen
ospleen or xenoliver (immediate phase and delayed phase): these phases
reflect different mechanisms of lymphocyte activation (a direct effec
tor action of splenic organ-specific factors on lymphocyte subpopulati
on, antigenic reaction of the body to xenotissues). The detected high
reactivity of mitochondrial complex in lymphocytes dependent on their
functional activity warrants informative value and short duration of t
he technique for estimation of changes in physiological state of lymph
ocytes in native blood in different impacts in vitro and in vivo. The
method is promising for follow-up control of the treatment efficacy.